fidarestat has been researched along with sb 239063 in 1 studies
| Studies (fidarestat) | Trials (fidarestat) | Recent Studies (post-2010) (fidarestat) | Studies (sb 239063) | Trials (sb 239063) | Recent Studies (post-2010) (sb 239063) |
|---|---|---|---|---|---|
| 97 | 3 | 33 | 84 | 0 | 35 |
| Protein | Taxonomy | fidarestat (IC50) | sb 239063 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.044 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.083 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.018 | |
| Protein kinase C alpha type | Homo sapiens (human) | 0.083 | |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | 0.005 | |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.044 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.044 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0415 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agthong, S; Middlemas, AB; Price, SA; Tomlinson, DR | 1 |
1 other study(ies) available for fidarestat and sb 239063
| Article | Year |
|---|---|
Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Activation; Enzyme Inhibitors; Ganglia, Spinal; Imidazoles; Imidazolidines; Insulin; Male; Mitogen-Activated Protein Kinases; Motor Neurons; Neural Conduction; Neurons, Afferent; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Wistar; Spinal Cord; Time Factors; Tissue Distribution | 2004 |